Clinical inertia is a significant concern in Type 2 Diabetes mellitus (T2DM) management , and overcoming it is crucial in improving long-term care for people with T2DM. There are patient-related, Physician-related & Healthcare-related factors to Clinical inertia. The barriers related to healthcare professionals that go beyond lack of time & training of diabetologists include: Lack of familiarity with the safety & efficacy of drug regimens. Lack of awareness of the latest guidelines to treat patients with T2DM.
Lack of clarity on the level of glycated hemoglobin (HbA1c) to be achieved for each patient. Few pertinent questions that demand the role of endocrinologists to cover the gap are: Which patients are appropriate candidates for safe and effective treatment intensification, and with which medications? What are the optimal timing and clinical context for treatment intensification whenβ¦